Dual Role of Neutrophils in Modulating Liver Injury and Fibrosis During Development and Resolution of Diet-induced Murine Steatohepatitis
Authors
Affiliations
Inflammatory changes in the liver represent a key feature of non-alcoholic steatohepatitis (NASH), the progressive form of non-alcoholic fatty liver disease (NAFLD). Innate immune activation including hepatic neutrophilic infiltration acts as an important inflammatory trigger as well as a potential mediator of inflammation resolution. In this study, we dissected the effects of neutrophil depletion via anti-lymphocyte antigen 6 complex locus G6D (Ly6G) antibodies administration during ongoing high fat-fructose-cholesterol (FFC) diet-induced murine NASH and during inflammation resolution by switching into a low-fat control diet. During NASH progression, protective effects were shown as HSC activation, cell infiltration and activation of pro-inflammatory macrophages were ameliorated. Furthermore, these changes were contrasted with the effects observed when neutrophil depletion was performed during the resolution phase. Impaired resolving mechanisms, such as a failure to balance the pro and anti-inflammatory cytokines ratio, deficient macrophage phenotypic switch into a pro-restorative profile, and defective repair and remodeling processes were observed when neutrophils were depleted in this scenario. This study described phase-dependent contrasting roles of neutrophils as triggers and pro-resolutive mediators of liver injury and fibrosis associated with diet-induced NASH in mice. These findings have important translational implications at the time of designing NASH therapeutic strategies.
Beyond host defense and tissue injury: the emerging role of neutrophils in tissue repair.
Rizo-Tellez S, Filep J Am J Physiol Cell Physiol. 2024; 326(3):C661-C683.
PMID: 38189129 PMC: 11193466. DOI: 10.1152/ajpcell.00652.2023.
Marinovic S, Lenartic M, Mladenic K, Sestan M, Kavazovic I, Benic A Sci Immunol. 2023; 8(87):eadd1599.
PMID: 37774007 PMC: 7615627. DOI: 10.1126/sciimmunol.add1599.
Stoess C, Leszczynska A, Kui L, Feldstein A Front Cell Dev Biol. 2023; 11:1218807.
PMID: 37664463 PMC: 10470644. DOI: 10.3389/fcell.2023.1218807.
Guo Y, Zhao C, Dai W, Wang B, Lai E, Xiao Y Int J Biol Sci. 2023; 19(8):2572-2587.
PMID: 37215993 PMC: 10197881. DOI: 10.7150/ijbs.83530.
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease.
Kotlyarov S World J Gastroenterol. 2023; 29(4):597-615.
PMID: 36742172 PMC: 9896611. DOI: 10.3748/wjg.v29.i4.597.